Enovix (ENVX) Current Deferred Revenue (2020 - 2026)

Enovix has reported Current Deferred Revenue for 7 years, with the latest figure at $4.6 million in Q2 2026.

• For the quarter ending Q2 2026, Current Deferred Revenue fell 33.33% year-over-year to $4.6 million; the trailing twelve-month figure through Apr 2026 stood at $4.6 million (down 33.33% YoY), and the FY2025 full-year result was $5.0 million, up 37.4% from the prior year.
• Current Deferred Revenue for Q2 2026 stood at $4.6 million, down from $5.0 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $10.8 million in Q2 2024, with the low at $275000.0 in Q3 2022.
• Historically, Current Deferred Revenue has averaged $5.9 million across 5 years, with a median of $5.6 million in 2022.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue tumbled 93.72% — and 2024, when it jumped 2500.0%.
• Enovix's Current Deferred Revenue stood at $1.4 million in 2022, then soared by 663.44% to $10.5 million in 2023, then slumped by 65.18% to $3.6 million in 2024, then surged by 37.4% to $5.0 million in 2025, then slipped by 8.28% to $4.6 million in 2026.
• The last three Current Deferred Revenue figures came in at $4.6 million (Q2 2026), $5.0 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.